Kesler Norman & Wride LLC trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE: UNH – Get Rating) by 0.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,901 shares of the healthcare conglomerate’s stock after selling 96 shares during the period. UnitedHealth Group comprises about 2.1% of Kesler Norman & Wride LLC’s portfolio, making the stock its 5th largest position. Kesler Norman & Wride LLC’s holdings in UnitedHealth Group were worth $ 9,639,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently modified their holdings of the stock. Palisades Hudson Asset Management LP boosted its holdings in UnitedHealth Group by 2.0% in the 4th quarter. Palisades Hudson Asset Management LP now owns 1,078 shares of the healthcare conglomerate’s stock valued at $ 542,000 after purchasing an additional 21 shares during the period. Charter Oak Capital Management LLC boosted its holdings in UnitedHealth Group by 2.4% in the 4th quarter. Charter Oak Capital Management LLC now owns 881 shares of the healthcare conglomerate’s stock valued at $ 442,000 after purchasing an additional 21 shares during the period. Oxford Financial Group Ltd. boosted its holdings in UnitedHealth Group by 3.0% in the 4th quarter. Oxford Financial Group Ltd. now owns 720 shares of the healthcare conglomerate’s stock valued at $ 362,000 after purchasing an additional 21 shares during the period. Griffin Asset Management Inc. raised its position in shares of UnitedHealth Group by 0.3% in the 1st quarter. Griffin Asset Management Inc. now owns 6,695 shares of the healthcare conglomerate’s stock valued at $ 3,414,000 after buying an additional 21 shares in the last quarter. Finally, Donald L. Hagan LLC raised its position in shares of UnitedHealth Group by 1.2% in the 4th quarter. Donald L. Hagan LLC now owns 1,854 shares of the healthcare conglomerate’s stock valued at $ 931,000 after buying an additional 22 shares in the last quarter. Institutional investors and hedge funds own 87.48% of the company stock.
Several equities analysts have recently commented on the stock. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $ 613.00 to $ 612.00 and set an “overweight” rating for the company in a research report on Wednesday, May 25th. Loop Capital started coverage on shares of UnitedHealth Group in a research report on Thursday, June 16th. They set a “buy” rating and a $ 575.00 price objective for the company. Cowen upped their price objective on shares of UnitedHealth Group from $ 512.00 to $ 596.00 in a research report on Monday, April 18th. Raymond James upped their price target on shares of UnitedHealth Group from $ 540.00 to $ 620.00 and gave the stock a “strong-buy” rating in a research report on Tuesday, April 19th. Finally, Sanford C. Bernstein cut shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $ 561.00 objective price for the company. in a research report on Thursday, May 26th. They noted that the move was a valuation call. Three research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $ 555.73.
NYSE: UNH opened at $ 499.81 on Friday. The firm’s fifty day moving average is $ 495.86 and its 200-day moving average is $ 491.14. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.78 and a current ratio of 0.78. UnitedHealth Group Incorporated has a 52 week low of $ 383.12 and a 52 week high of $ 553.29. The firm has a market cap of $ 468.91 billion, a P / E ratio of 27.36, a P / E / G ratio of 1.50 and a beta of 0.83.
UnitedHealth Group (NYSE: UNH – Get Rating) last issued its earnings results on Thursday, April 14th. The healthcare conglomerate reported $ 5.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $ 5.40 by $ 0.09. The business had revenue of $ 80.15 billion for the quarter, compared to analyst estimates of $ 78.77 billion. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. UnitedHealth Group’s revenue was up 14.2% on a year-over-year basis. During the same period in the prior year, the firm earned $ 5.31 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be paid a dividend of $ 1.65 per share. The ex-dividend date of this dividend is Thursday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $ 1.45. This represents a $ 6.60 annualized dividend and a yield of 1.32%. UnitedHealth Group’s dividend payout ratio is currently 36.12%.
In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the company stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $ 478.96, for a total transaction of $ 1,197,400.00. Following the transaction, the director now owns 1,215,000 shares in the company, valued at $ 581,936,400. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Frederick William Mcnabb III acquired 89 shares of the stock in a transaction on Thursday, May 26th. The shares were acquired at an average price of $ 504.32 per share, for a total transaction of $ 44,884.48. Following the acquisition, the director now owns 11,259 shares of the company stock, valued at approximately $ 5,678,138.88. The disclosure for this purchase can be found here. 0.40% of the stock is owned by corporate insiders.
About UnitedHealth Group: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Receive News & Ratings for UnitedHealth Group Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.